Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Affiliated Sites | All Access E-Edition | Home RSS
 
 
 

FDA reviews 2 new drugs to reduce prostate cancer

November 30, 2010
By MATTHEW PERRONE AP Health Writer

WASHINGTON - Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs' overall benefit, since the tumors they prevent are usually not life-threatening.

 
 

 

I am looking for:
in:
News, Blogs & Events Web